Unicancer

Unicancer is the only French hospital network 100% dedicated to the fight against cancer. It brings together the 18 French Comprehensive Cancer Centers, non-profit private healthcare facilities, spread across 20 hospital sites in France, along with 2 affiliated institutions. Unicancer is also the leading academic promoter of clinical trials in oncology on a European scale. Recognized as a leader in research in France, the Unicancer network enjoys a worldwide reputation, contributing to one-third of the internationally renowned French publications in oncology (source: bibliometric study/Thomson Reuters). Unicancer is also a pioneer in Real-World Data (RWD) research, with four national RWD platforms launched since 2014, involving around seventy healthcare facilities. These platforms have accumulated over 109,000 registered patients in the ESME program across three indications (metastatic breast cancer, ovarian cancer, and lung cancer), and more than 60,000 in the ODH program, a true observatory for medication and innovation, launched in 2021. Unicancer is also at the forefront of institution-level data mobilization, notably through the Unibase program.